Hungarian competition authorities have reportedly raided the local offices of French pharmaceutical conglomerate Sanofi in part of an investigation into suspicions that the company abused its market dominance.
Reports say the competition regulator GVH searched the offices on July 22; Sanofi confirmed the searches and said the company is fully cooperating with the investigation.
The GVH’s raids mark the launch of an investigation into concerns that the company abused its market power in regards to its wholesale trade contracts. Authorities said Sanofi refused to sign a contract with a Hungarian wholesale drug company. In a statement, GVH said that Sanofi’s practices to choose wholesale partners “is not based on the expected real economic efficiency of the link, while putting certain groups of market players into unjustified disadvantageous position relative to incumbent market players.”
Full content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UFC Reaches $375 Million Settlement in Antitrust Case
Feb 6, 2025 by
CPI
Brazilian Architecture Council Convicted of Antitrust Violations
Feb 6, 2025 by
CPI
Bipartisan Bill Seeks to Ban Chinese AI Software from US Government Devices
Feb 6, 2025 by
CPI
Senators Call for Investigation into RealPage Algorithm’s Impact on Military Housing Costs
Feb 6, 2025 by
CPI
ECB Seeks Faster Digital Euro Legislation Amid US Stablecoin Push
Feb 6, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – International Criminal Enforcement
Jan 23, 2025 by
CPI
The Antitrust Division’s Recent Work to Combat International Cartels
Jan 23, 2025 by
Emma Burnham & Benjamin Christenson
Information Sharing: The New Frontier of U.S. Antitrust Enforcement
Jan 23, 2025 by
Brian P. Quinn, Casey Kovarik & Michael Tubach
The Key Role of Guidelines on Exchanges of Information Among Competitors and the Divergent Transatlantic Paths
Jan 23, 2025 by
Rosa Abrantes-Metz & Albert Metz
Leniency, Whistleblowers, and Compliance
Jan 23, 2025 by
Richard Powers, Tara O’Malley & Cory Gordon